Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesCardiologypriority health Transcatheter Septal Closure Cover…
    Ask Trek AI about this page
    Modifiedpriority healthPolicy 91528

    TRANSCATHETER CLOSURE OF SEPTAL DEFECTS

    Customize your policy alerts

    Sign up for priority health Policy 91528 alerts

    Get alerted when Policy 91528 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs percutaneous transcatheter closure of congenital septal defects (atrial, select non-atrial) and related coding and coverage rules for Priority Health members; coverage depends on member benefits and medical necessity criteria.

    Policy Summary
    Payerpriority health
    PolicyTRANSCATHETER CLOSURE OF SEPTAL DEFECTS
    Policy CodePolicy 91528
    Change TypeMaterial revision (InterQual tieclarified exclusions)
    Effective DateAug 1, 2026
    Last ReviewMay 13, 2026
    Next Review DateMay 13, 2026
    Key ActionObtain and document InterQual® criteria fulfillment for percutaneous ASD closure; submit prior authorization when required.
    SourceLink
    POLICY UPDATE CHANGES

    Percutaneous transcatheter closure of congenital atrial septal defect is considered medically necessary when InterQual® criteria have been met.

    Clarified exclusions to transcatheter closure of septal defects.

    I.Medical necessity criteria section (ASD, non-ASD, exclusions)
    93580,93582Listed covered CPT/HCPCS codes
    93581,93799Explicitly not covered CPT codes

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    08/01/2026Policy effective date

    Coverage and Medical Necessity Criteria

    Medical necessity - Covered indications

    Covered when InterQual® criteria are met for percutaneous ASD repair and when indications for select non-atrial defects are present.

    ASD - Inclusions: Percutaneous transcatheter closure of congenital atrial septal defect is considered medically necessary when the following InterQual® criteria have been met: CP:Procedures Subset: Atrial Septal Defect (ASD) Repair Requested Service: Atrial Septal Defect (ASD) Repair, PercutaneousInterQual met

    Uses InterQual Procedures criteria; provider must document that InterQual criteria have been met

    Non-atrial defects considered medically necessary: Transcatheter closure of non-atrial septal defects using FDA-approved devices may be considered medically necessary for any of the following: 1. Patent ductus arteriosus (PDA) 2. Fenestration following a Fontan procedure 3. Ventricular septal defectspresence of listed indication

    Device must be FDA approved for indication; documentation should support indication and device approval

    Medically necessary — Percutaneous transcatheter closure of congenital atrial septal defect

    Covered when InterQual® criteria are met.

    Percutaneous ASD closure coverage: Percutaneous transcatheter closure of congenital atrial septal defect is considered medically necessary when InterQual® criteria have been met.InterQual criteria

    Documentation should demonstrate that InterQual® criteria have been met; failure to meet InterQual criteria will render the procedure not medically necessary and may result in denial.

    Transcatheter closure of septal defects is considered not medically necessary for indications other than those specifically listed as covered. The policy lists multiple exclusion conditions under which transcatheter closure is not appropriate, including but not limited to: severe pulmonary artery hypertension; right-to-left shunt; ostium primum, sinus venosus, or coronary sinus ASD; extensive congenital cardiac anomalies that require open cardiac surgery; inability to take antiplatelet or anticoagulant medications; presence of intracardiac thrombi on echocardiography; patient vasculature too small for the delivery system; any condition that contraindicates cardiac catheterization (for example, infection or sepsis); and defect location that would cause device interference with intracardiac or intravascular structures. The policy also expressly lists exclusions such as procedures performed for migraine prophylaxis, transmyocardial (perventricular) transcatheter closure of ventricular septal defects, and obstructive sleep apnea.

    Percutaneous transcatheter closure of congenital atrial septal defect is considered medically necessary only when the proprietary InterQual® criteria for ASD repair have been met; when InterQual® criteria are not met the procedure is considered not medically necessary and subject to denial. The policy change explicitly ties medical necessity for percutaneous ASD closure to meeting these InterQual® criteria.

    Exclusions to transcatheter closure of septal defects were clarified in the current revision. The policy emphasizes that detailed exclusion language appears in the policy body and confirms that the following remain exclusionary: severe pulmonary artery hypertension; right-to-left shunt; certain anatomic defect types (including ostium primum, sinus venosus, and coronary sinus ASD); extensive congenital cardiac anomalies only repairable by open surgery; inability to take required antiplatelet/anticoagulant therapy; intracardiac thrombi; insufficient patient vasculature for delivery systems; any contraindication to cardiac catheterization (e.g., infection, sepsis); and defect locations that would interfere with adjacent intracardiac or intravascular structures. The revision note indicates these exclusions were clarified in this update.

    Percutaneous transcatheter closure of congenital atrial septal defect is considered NOT medically necessary when the relevant InterQual® criteria have NOT been met. Providers should ensure that documentation submitted for review demonstrates that the InterQual® Procedures subset for Atrial Septal Defect (ASD) Repair — Percutaneous is satisfied. If InterQual® criteria are not met, the service is noncovered and is at risk for denial under this policy.

    The policy lists CPT 93581 (Percutaneous transcatheter closure of a congenital ventricular septal defect with implant) and unlisted code 93799 (Unlisted cardiovascular service or procedure for transcatheter ventricular septal defect procedures) as Not Covered. Claims submitted with these codes for transcatheter ventricular septal defect procedures will not be covered under this policy and, where 93799 is used, explanatory documentation accompanying the claim does not make the procedure covered.

    Documentation and prior authorization expectations: when prior authorization is required for devices, services, or procedures (for example, covered CPT/HCPCS such as 93580, 93582, or device codes like C1817 and C2628), providers must submit requests that demonstrate medical necessity per Priority Health procedures. Claims should include supporting ICD-10 diagnosis codes that may support medical necessity (for example, Q21.10–Q21.19 for ASD, Q25.0 for PDA, and related codes) and the applicable procedure and device codes. Specifically, documentation should demonstrate that the InterQual® criteria have been met for percutaneous transcatheter closure of congenital atrial septal defect; failure to provide InterQual®-based documentation when required creates a denial risk because the procedure is considered not medically necessary if InterQual® criteria are not satisfied.

    Denial Risk

    Not medically necessary when InterQual® criteria are not met

    Percutaneous transcatheter closure of congenital atrial septal defect is considered NOT medically necessary when the InterQual® criteria have not been met. Providers must confirm InterQual® criteria are satisfied before proceeding to avoid a determination of non‑medical necessity.

    Billing and Coding

    Covered CPT/HCPCS CodesCPTCovered
    93580Percutaneous transcatheter closure of congenital interatrial communication (i.e., Fontan fenestration, atrial septal defect) with implant
    93582Percutaneous transcatheter closure of patent ductus arteriosus
    C1817Septal defect implant system, intracardiac
    C2628Catheter, occlusion
    Not CoveredCPTNot Covered
    93581Percutaneous transcatheter closure of a congenital ventricular septal defect with implant
    93799Unlisted cardiovascular service or procedure (for transcatheter ventricular septal defect procedure - explanatory notes must accompany claim)
    ICD-10 Codes that may support medical necessityICD-10
    G45.0-G45.9Transient cerebral ischemic attacks and related syndromes
    I23.1Atrial septal defect as current complication following acute myocardial infarction
    I51.0Cardiac septal defect, acquired
    I63.9Cerebral infarction, unspecified
    Q21.10-Q21.19Atrial septal defect
    Q21.20-Q21.23Atrioventricular septal defect
    Q25.0Patent ductus arteriosus

    Provider Requirements, Prior Authorization, and Documentation

    Prior Authorization

    Prior authorization may be required

    Prior authorization may be required for certain devices, services, and procedures; when required, providers must submit a request demonstrating that the service is medically necessary per Priority Health procedures (see Provider Manual).

    • Follow Priority Health Provider Manual submission instructions when PA is required.
    • Requests for individual consideration require prior plan approval and review by a Priority Health medical director or clinical pharmacist.
    Note

    InterQual® criteria required for coverage

    Percutaneous transcatheter closure of congenital atrial septal defect is covered only when the InterQual® criteria for ASD repair have been met; coverage is contingent on meeting those InterQual® procedures criteria.

    • Requested service referenced: Atrial Septal Defect (ASD) Repair, Percutaneous (InterQual: CP:Procedures Subset: Atrial Septal Defect Repair).

    Background and Clinical Context

    An atrial septal defect (ASD) produces a left‑to‑right shunt that increases pulmonary blood flow and can lead to ventricular volume or pressure overload, progressive pulmonary hypertension, arrhythmia, and risk of stroke. Transcatheter septal occluders are permanently implanted devices delivered percutaneously as a less invasive alternative to open surgical repair; these devices are FDA‑classified as Class III under applicable product codes. Preprocedural assessment must identify contraindications such as severe pulmonary artery hypertension (for example, pulmonary arterial systolic pressure or pulmonary vascular resistance approximating greater than two‑thirds systemic), which would generally preclude transcatheter closure.

    Definitions and Device Information

    Transcatheter septal occluder — device definition and regulatory class
    DefinitionAn implantable cardiac device delivered percutaneously to close septal wall defects (atrial or ventricular); used as a less-invasive alternative to open-heart surgery.
    FDA regulatory classClass III cardiovascular device requiring premarket approval (PMA) under core product codes such as OZG (Transcatheter Septal Occluder - Atrial) and MLV (Transcatheter Septal Occluder).
    Intended usePermanent intracardiac occlusion of septal defects to eliminate left-to-right shunt and reduce risks of volume/pressure overload, pulmonary hypertension, arrhythmia, and stroke.
    Delivery routePercutaneous access via the venous system (e.g., internal jugular or femoral vein) with catheter-based deployment to the septal defect.
    InterQual® criteria — explanation of proprietary criteria referenced
    Policy Summary
    Payerpriority health
    PolicyTRANSCATHETER CLOSURE OF SEPTAL DEFECTS
    Policy CodePolicy 91528
    Change TypeMaterial revision (InterQual tieclarified exclusions)
    Effective DateAug 1, 2026
    Last ReviewMay 13, 2026
    Next Review DateMay 13, 2026
    Key ActionObtain and document InterQual® criteria fulfillment for percutaneous ASD closure; submit prior authorization when required.
    SourceLink
    On This Page
    Coverage and Medical Necessity CriteriaBilling and CodingProvider Requirements, Prior Authorization, and DocumentationBackground and Clinical ContextDefinitions and Device Information
    Documentation Required

    Provide clear clinical indication and findings

    Ensure any prior authorization or case review request clearly documents the indication and relevant clinical findings supporting medical necessity.

    Prior Authorization

    Request prior approval for individual case review

    If requesting individual case review for investigational or promising treatments, obtain prior plan approval and include supporting rationale for exception.

    • Individual consideration requires prior plan approval.
    • All determinations for experimental, investigational, or unproven treatments are made by a Priority Health medical director or clinical pharmacist.
    Billing Rule

    Include supporting ICD-10 and procedure/device codes

    Claims should include supporting ICD-10 diagnosis codes that may support medical necessity and the applicable CPT/HCPCS procedure and device codes.

    • Relevant ICD-10 codes include Q21.10–Q21.19 (ASD), Q25.0 (PDA), I23.1, and others listed in the policy.
    • Include procedure/device codes such as CPT 93580, 93582 and HCPCS C1817, C2628 as applicable.
    Documentation Required

    Document that InterQual® criteria are met

    Documentation submitted for authorization or claims should demonstrate that the InterQual® criteria have been met for percutaneous transcatheter closure of congenital atrial septal defect.

    • Reference the specific InterQual® Procedures ASD Repair criteria used to justify medical necessity.
    Denial Risk

    Denial risk if InterQual® criteria not met

    Failure to meet the InterQual® criteria for percutaneous transcatheter closure of congenital atrial septal defect would risk denial of coverage.

    What it is
    A proprietary, evidence-based set of clinical criteria (InterQual®) referenced by the policy to determine medical necessity for percutaneous atrial septal defect (ASD) repair.
    Role in this policyMedical necessity for percutaneous transcatheter closure of congenital ASD is conditioned on meeting the applicable InterQual® Procedures (ASD Repair) criteria.
    Documentation expectationProviders must document that InterQual® criteria have been met in supporting authorization and claims documentation.
    ScopeInterQual® criteria are referenced but the detailed criteria set is not reproduced in this policy document window.
    InterQual® — short keyvalue entry
    Referenced InterQual subsetCP: Procedures, Subset: Atrial Septal Defect (ASD) Repair — Requested Service: Atrial Septal Defect (ASD) Repair, Percutaneous.
    Coverage conditionPercutaneous transcatheter closure of congenital ASD is considered medically necessary when InterQual® criteria have been met.
    Consequence if not metPercutaneous transcatheter closure of congenital ASD is considered NOT medically necessary when InterQual® criteria have NOT been met (denial risk).
    Policy change notePolicy explicitly ties medical necessity for percutaneous ASD closure to meeting InterQual® criteria (effective 08/01/2026).